Eli Lilly’s positive results from a Alzheimer’s trial seen as ‘potentially very important’
May 03, 2023 at 14:07 PM EDT
Eli Lilly’s positive trial showed that the drug donanemab 'significantly slowed cognitive and functional decline' in patients.
